ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e
Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
M.V.I.-12 ADULT is a multi-vitamin injectable formulation containing 12 essential vitamins (A, B-complex, C, D, E) administered intravenously. It is indicated for patients unable to obtain adequate vitamin intake via oral routes, particularly those on total parenteral nutrition (TPN) or with severe malabsorption. The product corrects and prevents vitamin deficiencies in hospitalized and critically ill populations.
As a mature product with LOE approaching, the brand team is likely in maintenance mode with limited headcount expansion; career opportunities focus on defensive strategy and cost optimization rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Careers on M.V.I.-12 ADULT focus on defending market share, managing hospital relationships, and optimizing manufacturing and logistics in a mature, commoditized category. This is a stable but limited-growth opportunity best suited for professionals seeking operational excellence and strategic cost management rather than innovation-driven advancement.
Worked on M.V.I.-12 ADULT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.